Skip to main content
Clinical Trials/NCT02364674
NCT02364674
Completed
Not Applicable

Transplant Optimization Using Functional Imaging

FLUIDDA nv2 sites in 1 country8 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bronchiolitis Obliterans
Sponsor
FLUIDDA nv
Enrollment
8
Locations
2
Primary Endpoint
Lobe volumes (iVlobes)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The objective of this study is to detect Bronchiolitis Obliterans Syndrome (BOS) in an early stage using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust and automated segmentation algorithms will be developed for these parameters, focusing on quantitative computed tomography (CT) image analyses to provide the physician a more sensitive diagnostics tool. The evolution of BOS over time will be monitored using non-rigid image registration methods.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
January 9, 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
FLUIDDA nv
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female patient ≥ 18 years old
  • Written informed consent obtained
  • Patient who had undergone a lung transplant a year ago or more.
  • Female patient of childbearing potential who confirm that a contraception method was used at least 14 days before visit 1 and will continue to use a contraception method during the study
  • The patient must be able to perform the lung monitoring at home.

Exclusion Criteria

  • Pregnant or lactating female
  • Known history of or active airways or anastomotic complications requiring intervention such as stenting or dilation

Outcomes

Primary Outcomes

Lobe volumes (iVlobes)

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Specific Airway Resistance (siRaw)

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Airway Volume (iVaw)

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Blood Vessel Density or Fibrosis Score

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Internal Lobar Airflow Distribution

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Air trapping

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Airway Resistance (iRaw)

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Specific Airway Volume (siVaw)

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Low Attenuation or Emphysema Score

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Airway Wall Thickness

Time Frame: 12 months

Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Study Sites (2)

Loading locations...

Similar Trials